The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine VMIP- I is a specific agonist for the CC chemokine receptor (CCR)8

142Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

The Kaposi's sarcoma-related herpesvirus (KSHV), also designated human herpesvirus 8, is the presumed etiologic agent of Kaposi's sarcoma and certain lymphomas. Although KSHV encodes several chemokine homologues (viral macrophage inflammatory protein [vMIP]-I, -II, and -III), only vMIP-II has been functionally characterized. We report here that vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8 that is preferentially expressed on Th2 T cells. Y3 cells transfected with CCR8 produced a calcium flux in response to vMIP-I and responded vigorously in in vitro chemotaxis assays. In competition binding experiments, the interaction of vMIP-I with CCR8 was shown to be specific and of high affinity. In contrast to its agonist activity at CCR8, vMIP-I did not interact with CCR5 or any of 11 other receptors examined. Furthermore, vMIP-I was unable to inhibit CCR5-mediated HIV infection. These findings suggest that expression of vMIP-I by KSHV may influence the Th1/Th2 balance of the host immune response.

Cite

CITATION STYLE

APA

Endres, M. J., Garlisi, C. G., Xiao, H., Shan, L. X., & Hedrick, J. A. (1999). The Kaposi’s sarcoma-related herpesvirus (KSHV)-encoded chemokine VMIP- I is a specific agonist for the CC chemokine receptor (CCR)8. Journal of Experimental Medicine, 189(12), 1993–1998. https://doi.org/10.1084/jem.189.12.1993

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free